Charities Start Pharmaceutical Enterprises
March 24, 2006
Large grants from the Bill & Melinda Gates Foundation and other wealthy philanthropies are making it possible for nonprofit biotechnology groups like the Aeras Global TB Vaccine Foundation to pursue projects that only for-profit drug makers could previously afford, reports The Washington Post.
Aeras, which hopes to find a new tuberculosis vaccine, is taking a “businesslike approach” to public health, cutting the risk of testing one potential drug by investing in many drugs, the newspaper says.
